• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中风后 MMPs 的 mRNA 表达谱:MMP-12 基因缺失的影响。

Post-stroke mRNA expression profile of MMPs: effect of genetic deletion of MMP-12.

机构信息

Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA.

Department of Neurosurgery, University of Illinois College of Medicine, Peoria, Illinois, USA.

出版信息

Stroke Vasc Neurol. 2018 Mar 9;3(3):153-159. doi: 10.1136/svn-2018-000142. eCollection 2018 Sep.

DOI:10.1136/svn-2018-000142
PMID:30294471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6169614/
Abstract

BACKGROUND AND PURPOSE

Recent reports from our laboratory demonstrated the post-ischaemic expression profile of various matrix metalloproteinases (MMPs) in rats and the detrimental role of MMP-12 in post-stroke brain damage. We hypothesise that the post-stroke dysregulation of MMPs is similar across species and that genetic deletion of MMP-12 would not affect the post-stroke expression of other MMPs. We tested our hypothesis by determining the pre-ischaemic and post-ischaemic expression profile of MMPs in wild-type and MMP-12 knockout mice.

METHODS

Focal cerebral ischaemia was induced in wild-type and MMP-12 knockout mice by middle cerebral artery occlusion procedure by insertion of a monofilament suture. One hour after ischaemia, reperfusion was initiated by removing the monofilament. One day after reperfusion, ischaemic brain tissues from various groups of mice were collected, and total RNA was isolated and subjected to cDNA synthesis followed by PCR analysis.

RESULTS

Although the post-stroke expression profile of MMPs in the ischaemic brain of mice is different from rats, there is a clear species similarity in the expression of MMP-12, which was found to be predominantly upregulated in both species. Further, the post-stroke induction or inhibition of various MMPs in MMP-12 knockout mice is different from their respective expression profile in wild-type mice. Moreover, the brain mRNA expression profile of various MMPs in MMP-12 knockout mice under normal conditions is also different to their expression in wild-type mice.

CONCLUSIONS

In the ischaemic brain, MMP-12 upregulates several fold higher than any other MMP. Mice derived with the genetic deletion of MMP-12 are constitutive and have altered MMP expression profile both under normal and ischaemic conditions.

摘要

背景与目的

本实验室近期的研究报告表明,基质金属蛋白酶(MMPs)在大鼠缺血后的表达谱存在差异,MMP-12 在卒中后脑损伤中发挥有害作用。我们假设,卒中后 MMPs 的失调在不同物种中是相似的,并且 MMP-12 的基因缺失不会影响卒中后其他 MMPs 的表达。我们通过检测野生型和 MMP-12 敲除小鼠缺血前和缺血后的 MMPs 表达谱来验证我们的假设。

方法

通过插入单丝缝线的方法,在野生型和 MMP-12 敲除小鼠中诱导局灶性脑缺血。缺血 1 小时后,通过移除单丝缝线来启动再灌注。再灌注 1 天后,从各组小鼠的缺血脑组织中收集总 RNA,并进行 cDNA 合成和 PCR 分析。

结果

尽管小鼠缺血脑内 MMPs 的卒中后表达谱与大鼠不同,但 MMP-12 的表达存在明显的物种相似性,其在两种物种中均被明显上调。此外,MMP-12 敲除小鼠卒中后各种 MMP 的诱导或抑制与其在野生型小鼠中的表达谱不同。此外,MMP-12 敲除小鼠在正常条件下的各种 MMP 的脑 mRNA 表达谱也与其在野生型小鼠中的表达谱不同。

结论

在缺血脑内,MMP-12 的上调幅度比任何其他 MMP 都高几个数量级。源自 MMP-12 基因缺失的小鼠在正常和缺血条件下均具有组成型和改变的 MMP 表达谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/d5db20202c5f/svn-2018-000142f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/9b8026e10b05/svn-2018-000142f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/9977dde5f16f/svn-2018-000142f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/d5db20202c5f/svn-2018-000142f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/9b8026e10b05/svn-2018-000142f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/9977dde5f16f/svn-2018-000142f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/6169614/d5db20202c5f/svn-2018-000142f03.jpg

相似文献

1
Post-stroke mRNA expression profile of MMPs: effect of genetic deletion of MMP-12.中风后 MMPs 的 mRNA 表达谱:MMP-12 基因缺失的影响。
Stroke Vasc Neurol. 2018 Mar 9;3(3):153-159. doi: 10.1136/svn-2018-000142. eCollection 2018 Sep.
2
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.组织型纤溶酶原激活剂在局灶性脑缺血后促进基质金属蛋白酶-9上调。
Stroke. 2005 Sep;36(9):1954-9. doi: 10.1161/01.STR.0000177517.01203.eb. Epub 2005 Jul 28.
3
Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model.基因沉默基质金属蛋白酶-9在大脑中动脉闭塞诱导的局灶性缺血大鼠模型中的治疗应用。
Exp Neurol. 2009 Mar;216(1):35-46. doi: 10.1016/j.expneurol.2008.11.007. Epub 2008 Nov 24.
4
MMP-3 Knockout Induces Global Transcriptional Changes and Reduces Cerebral Infarction in Both Male and Female Models of Ischemic Stroke.MMP-3 基因敲除可诱导缺血性脑卒中雄性和雌性模型的全转录组变化,并减少脑梗死。
Int J Mol Sci. 2024 Jul 5;25(13):7383. doi: 10.3390/ijms25137383.
5
Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases.间充质干细胞治疗可预防中风后基质金属蛋白酶及其组织抑制剂的失调。
Cell Physiol Biochem. 2017;44(4):1360-1369. doi: 10.1159/000485533. Epub 2017 Nov 30.
6
Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.窖蛋白-1 调节局灶性脑缺血再灌注损伤中一氧化氮介导的基质金属蛋白酶活性和血脑屏障通透性。
J Neurochem. 2012 Jan;120(1):147-56. doi: 10.1111/j.1471-4159.2011.07542.x. Epub 2011 Nov 17.
7
Induced mRNA expression of matrix metalloproteinases Mmp-3, Mmp-12, and Mmp-13 in the infarct cerebral cortex of photothrombosis model mice.诱导型基质金属蛋白酶 Mmp-3、Mmp-12 和 Mmp-13 在光血栓模型小鼠梗死大脑皮质中的 mRNA 表达。
Neurosci Lett. 2020 Nov 20;739:135406. doi: 10.1016/j.neulet.2020.135406. Epub 2020 Sep 25.
8
Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.缺血后 p66Shc 沉默减轻缺血/再灌注脑损伤,其表达与脑卒中临床结局相关。
Eur Heart J. 2015 Jul 1;36(25):1590-600. doi: 10.1093/eurheartj/ehv140. Epub 2015 Apr 22.
9
Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.大鼠局灶性脑缺血后基质金属蛋白酶表达增加:抑制基质金属蛋白酶-9可减小梗死灶大小。
Stroke. 1998 May;29(5):1020-30. doi: 10.1161/01.str.29.5.1020.
10
Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.在梗阻性肾病中,巨噬细胞浸润和肾损伤与基质金属蛋白酶 12 无关。
Nephrology (Carlton). 2012 May;17(4):322-9. doi: 10.1111/j.1440-1797.2012.01567.x.

引用本文的文献

1
Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke.实验性脑卒中与脑缺血持续时间及组织型纤溶酶原激活剂治疗相关的基质金属蛋白酶-9、3、2 的急性表达差异。
Int J Mol Sci. 2024 Aug 30;25(17):9442. doi: 10.3390/ijms25179442.
2
In vitro dose-dependent effects of matrix metalloproteinases on ECM hydrogel biodegradation.基质金属蛋白酶对细胞外基质水凝胶生物降解的体外剂量依赖性影响。
Acta Biomater. 2024 Jan 15;174:104-115. doi: 10.1016/j.actbio.2023.12.003. Epub 2023 Dec 10.
3
Implications of MMP-12 in the pathophysiology of ischaemic stroke.

本文引用的文献

1
Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice.基质金属蛋白酶组织抑制剂和基质金属蛋白酶在光血栓形成模型小鼠缺血脑中的表达
Neuroreport. 2018 Feb 7;29(3):174-180. doi: 10.1097/WNR.0000000000000946.
2
Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases.间充质干细胞治疗可预防中风后基质金属蛋白酶及其组织抑制剂的失调。
Cell Physiol Biochem. 2017;44(4):1360-1369. doi: 10.1159/000485533. Epub 2017 Nov 30.
3
New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
基质金属蛋白酶-12 在缺血性脑卒中病理生理学中的意义。
Stroke Vasc Neurol. 2024 Apr 30;9(2):97-107. doi: 10.1136/svn-2023-002363.
4
Dexmedetomidine Increases MMP-12 and MBP Concentrations after Coronary Artery Bypass Graft Surgery with Extracorporeal Circulation Anaesthesia without Impacting Cognitive Function: A Randomised Control Trial.右美托咪定在体外循环麻醉下增加冠状动脉旁路移植手术后 MMP-12 和 MBP 浓度,但不影响认知功能:一项随机对照试验。
Int J Environ Res Public Health. 2022 Dec 8;19(24):16512. doi: 10.3390/ijerph192416512.
5
The interplay between MMP-12 and t-PA in the brain after ischemic stroke.缺血性脑卒中后大脑中 MMP-12 和 t-PA 的相互作用。
Neurochem Int. 2022 Dec;161:105436. doi: 10.1016/j.neuint.2022.105436. Epub 2022 Oct 23.
6
Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration.基质金属蛋白酶-12抑制对缺血性中风后神经功能恢复的治疗效果:最佳治疗时机和持续时间
Front Neurosci. 2022 Oct 4;16:1012812. doi: 10.3389/fnins.2022.1012812. eCollection 2022.
7
Bioactive Flavonoids Icaritin and Icariin Protect against Cerebral Ischemia-Reperfusion-Associated Apoptosis and Extracellular Matrix Accumulation in an Ischemic Stroke Mouse Model.生物活性黄酮类化合物淫羊藿素和淫羊藿苷在缺血性中风小鼠模型中可预防脑缺血再灌注相关的细胞凋亡和细胞外基质积聚。
Biomedicines. 2021 Nov 19;9(11):1719. doi: 10.3390/biomedicines9111719.
8
Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly.中风中的神经炎症与纤维化:有益、有害与丑陋之处
J Neuroimmunol. 2020 Jul 9;346:577318. doi: 10.1016/j.jneuroim.2020.577318.
实验性缺血性卒中的新溶栓策略:基质金属蛋白酶 10 单独或与组织型纤溶酶原激活剂联合应用。
Cardiovasc Res. 2017 Aug 1;113(10):1219-1229. doi: 10.1093/cvr/cvx069.
4
Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice.基质金属蛋白酶-13参与小鼠脑缺血后的神经保护和神经修复。
Neurobiol Dis. 2016 Jul;91:236-46. doi: 10.1016/j.nbd.2016.03.016. Epub 2016 Mar 19.
5
Matrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic Stroke.基质金属蛋白酶3加剧高血糖性卒中的出血性转化并恶化功能预后。
Stroke. 2016 Mar;47(3):843-51. doi: 10.1161/STROKEAHA.115.011258. Epub 2016 Feb 2.
6
Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.基质金属蛋白酶-12在局灶性脑缺血后诱导血脑屏障损伤。
Stroke. 2015 Dec;46(12):3523-31. doi: 10.1161/STROKEAHA.115.011031. Epub 2015 Nov 3.
7
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage.局灶性脑缺血后基质金属蛋白酶-12的转录后失活减轻脑损伤。
Sci Rep. 2015 May 8;5:9504. doi: 10.1038/srep09504.
8
Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.基质金属蛋白酶-8 是局灶性脑缺血的新型致病因素。
Mol Neurobiol. 2016 Jan;53(1):231-239. doi: 10.1007/s12035-014-8996-y. Epub 2014 Nov 26.
9
Stem cell treatment after cerebral ischemia regulates the gene expression of apoptotic molecules.脑缺血后干细胞治疗可调节凋亡分子的基因表达。
Neurochem Res. 2014 Aug;39(8):1511-21. doi: 10.1007/s11064-014-1341-z. Epub 2014 May 31.
10
Mmp-9 inhibition: a therapeutic strategy in ischemic stroke.基质金属蛋白酶-9抑制:缺血性卒中的一种治疗策略
Mol Neurobiol. 2014 Feb;49(1):563-73. doi: 10.1007/s12035-013-8538-z. Epub 2013 Sep 12.